chrX-18642011-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000330.4(RS1):c.668G>A(p.Cys223Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C223G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000330.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RS1 | NM_000330.4 | c.668G>A | p.Cys223Tyr | missense_variant | 6/6 | ENST00000379984.4 | |
RS1 | XM_047442337.1 | c.572G>A | p.Cys191Tyr | missense_variant | 4/4 | ||
CDKL5 | NM_001037343.2 | c.2714-3996C>T | intron_variant | ||||
CDKL5 | NM_003159.3 | c.2714-3996C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RS1 | ENST00000379984.4 | c.668G>A | p.Cys223Tyr | missense_variant | 6/6 | 1 | NM_000330.4 | P1 | |
CDKL5 | ENST00000379989.6 | c.2714-3996C>T | intron_variant | 1 | |||||
CDKL5 | ENST00000379996.7 | c.2714-3996C>T | intron_variant | 1 | |||||
RS1 | ENST00000476595.1 | n.1159G>A | non_coding_transcript_exon_variant | 5/5 | 1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 17, 2023 | This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 223 of the RS1 protein (p.Cys223Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with retinoschisis (PMID: 20061330, 22245991). ClinVar contains an entry for this variant (Variation ID: 372497). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RS1 protein function. This variant disrupts the p.Cys223 amino acid residue in RS1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10533068, 16361673, 30652005; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 17, 2015 | The C223Y missense variant in the RS1 gene has been reported previously in association with X-linked juvenile retinoschisis (Sergeev et al., 2010). Molecular modeling indicated that the C223Y substitution breaks a disulfide bond within the discoidin domain of the protein, decreasing stability of this domain and possibly affecting protein conformation (Sergeev et al., 2010). Therefore, we interpret C223Y as a pathogenic variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at